関連する実験動画
Updated: Sep 10, 2025

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.4K
甲状腺がん細胞の移動と侵入を抑制する
Domenico Rocco1, Vincenzo Marotta1, Domenico Palumbo1
1Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Baronissi, Salerno, Italy.
International journal of molecular sciences
|August 28, 2025
まとめ
マトリックス金属タンパク質酵素 (MMPs) は,パピラー甲状腺がん (PTC) の進行を促します. MMP-14 (NSC405020) とMMP-2/MMP-9 (ガリック酸) を阻害することは,新しいPTC治療に有望である.
科学分野:
- 腫瘍学
- 分子生物学
- 生物化学
背景:
- パピラー性甲状腺癌 (PTC) は,一般的に好ましい予後にもかかわらず,攻撃的な行動を示す可能性があります.
- マトリックス金属タンパク質酵素 (MMPs) は細胞外マトリックス改造における重要な酵素であり,腫瘍の侵入と転移に影響を与える.
- 甲状腺の悪性腫瘍を含む様々な癌の進行に関与している.
研究 の 目的:
- 乳頭甲状腺がんにおけるMMPの発現と活性を調べる.
- PTC細胞の移動と侵入を抑制する選択的なMMP阻害剤の有効性を評価する.
主な方法:
- TCGA-THCAデータセットから得られたRNAシーケンシングデータを分析して,差異的に発現するMMPを特定する.
- PTC細胞系 (K1,BCPAP) と非腫瘍性甲状腺細胞 (Nthy-ori 3-1) でのMMP発現と活性の検証
- MMP - 14 阻害剤 (NSC405020) とMMP - 2/MMP - 9 阻害剤 (ガリック酸) がPTC細胞の移動と侵入に及ぼす影響の評価
主要な成果:
- MMP-14はPTCで有意に過剰発現し,疾患状態と再発リスクと相関していました.
- PTC細胞系では,正常細胞と比較して,MMP - 14,MMP - 2,MMP - 9の活性が顕著に増加した.
- NSC405020はK1細胞の移動 (56. 52%) と侵入 (67. 3%) を抑制し,ガリック酸は移動 (60. 3%) と侵入 (33. 3%) を減少させた.
結論:
- MMP,特にMMP- 14の活性が上昇することは,侵襲的な乳頭甲状腺がんの特徴です.
- NSC405020やガリック酸のような特定の阻害剤でMMPを標的にすることは,PTCの潜在的な治療戦略です.
- これらの発見は,PTCの進行におけるMMPの重要な役割を強調し,新しい治療の開発の機会を提供します.
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Role of Matrix Metalloproteases in Degradation of ECM
2.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.5K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K

